-
EP2094681
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2094681
| EP2094681 - INDOL-4-YL-PYRIMIDINYL-2-YL-AMINE DERIVATIVES AND USE THEREOF AS CYCLIN DEPENDANT KINASE INHIBITORS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.02.2011 Database last updated on 15.11.2024 | Most recent event Tooltip | 25.02.2011 | Application deemed to be withdrawn | published on 30.03.2011 [2011/13] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [N/P] |
| Former [2009/36] | For all designated states NOVARTIS AG Lichtstrasse 35 4056 Basel / CH | Inventor(s) | 01 /
BECKWITH, Rohan Eric John 250 Massachusetts Avenue Cambridge, Massachusetts 02139 / US | [2009/36] | Representative(s) | Vögeli-Lange, Regina Novartis Pharma AG Patent Department 4002 Basel / CH | [N/P] |
| Former [2009/36] | Vögeli-Lange, Regina Novartis Pharma AG Patent Department 4002 Basel / CH | Application number, filing date | 07865903.4 | 20.12.2007 | [2009/36] | WO2007US88267 | Priority number, date | US20060871469P | 22.12.2006 Original published format: US 871469 P | [2009/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008079918 | Date: | 03.07.2008 | Language: | EN | [2008/27] | Type: | A1 Application with search report | No.: | EP2094681 | Date: | 02.09.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.07.2008 takes the place of the publication of the European patent application. | [2009/36] | Search report(s) | International search report - published on: | EP | 03.07.2008 | Classification | IPC: | C07D401/04, C07D403/04, C07D403/14, C07D471/04, C07D487/04, A61K31/506, A61P35/00 | [2009/36] | CPC: |
C07D403/04 (EP,US);
C07D487/04 (EP,KR,US);
A61K31/506 (KR);
A61P13/12 (EP);
A61P17/02 (EP);
A61P25/00 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P31/12 (EP);
A61P31/14 (EP);
A61P31/18 (EP);
A61P35/00 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
C07D401/04 (EP,US);
C07D401/14 (EP,US);
C07D403/14 (EP,US);
C07D417/14 (EP,US);
C07D471/04 (EP,KR,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/36] | Title | German: | INDOL-4-YLPYRIMIDINYL-2-YL-AMINDERIVATE UND DEREN VERWENDUNG ALS INHIBITOREN DER CYCLINABHÄNGIGEN KINASE | [2009/36] | English: | INDOL-4-YL-PYRIMIDINYL-2-YL-AMINE DERIVATIVES AND USE THEREOF AS CYCLIN DEPENDANT KINASE INHIBITORS | [2009/36] | French: | DÉRIVÉS D'INDOL-4-YL-PYRIMIDINYL-2-YL-AMINE ET LEUR UTILISATION COMME INHIBITEURS DE LA KINASE DÉPENDANTE DES CYCLINES | [2009/36] | Entry into regional phase | 22.07.2009 | National basic fee paid | 22.07.2009 | Designation fee(s) paid | 22.07.2009 | Examination fee paid | Examination procedure | 22.07.2009 | Examination requested [2009/36] | 07.09.2009 | Amendment by applicant (claims and/or description) | 23.03.2010 | Despatch of a communication from the examining division (Time limit: M06) | 05.10.2010 | Application deemed to be withdrawn, date of legal effect [2011/13] | 10.11.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/13] | Fees paid | Renewal fee | 11.12.2009 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.12.2010 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9744326 (HOFFMANN LA ROCHE [CH]) [X] 1-12* compounds on page 59, lines 23-34 compound on page 63, lines 29-30 compounds on page 69, lines 30-33 *; | [X]WO2005065074 (UNIV TEMPLE [US], et al) [X] 1-20 * compound on page 21, lines 16-17 *; | [X]WO2006124863 (IRM LLC [US], et al) [X] 1-12,21-50 * claims 1,7 * * examples on pages 23-43 *; | [X]US2006270686 (KELLY MARTHA [US], et al) [X] 1-50 * claims 1,133 * * example 31 *; | [PX]WO2007042810 (LUDWIG INST CANCER RES [CH], et al) [PX] 1-12 * claims 1,10 * * compounds I4 on page 43, K4 on page 44 and M4 on page 45 *; | [PX] - HUANG ET AL, "Synthesis and biological study of 2-amino-4-aryl-5-chloropyrimidine analogues as inhibitors of VEGFR-2 and cyclin dependent kinase 1 (CDK1)", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (20070330), vol. 17, no. 8, ISSN 0960-894X, pages 2179 - 2183, XP022009228 [PX] 1-50 * abstract * * compound 9d, table 2 * DOI: http://dx.doi.org/10.1016/j.bmcl.2007.01.086 |